⚡ Webinar Synopsis: In this webinar, OracleBio’s Chief Scientific Officer, Lorcan Sherry, and Senior Business Development Manager, Keith Bowers, provide an overview of OracleBio’s image analysis workflow, highlighting quality control, clinical pathologist integration, algorithm development, data integrity, and collaboration tools, with real-world case studies showcasing the value added to Pharma R&D.
📩 Newsletter: Subscribe now for the latest Webinars, Videos, Articles & more! →
OracleBio is a global leader in quantitative digital pathology services to Pharma and Biotech clients worldwide. Leveraging industry-leading image analysis software platforms, the company delivers robust data packages to support clinical trials and translational research. As image analysis experts, OracleBio specialises in cellular phenotyping of multiplex stained tissue and has built a strong reputation as the go-to company for complex image analysis.
In this webinar, Keith and Lorcan give an overview of OracleBio’s image analysis study workflow including:
• Quality control procedures to generate data you can trust
• Integrating clinical pathologists into image analysis workflow
• Algorithm development and ensuring data integrity
• Collaboration and sharing of analysis and results via image viewing portal
• Three Case Studies giving real-world examples of how OracleBio’s services can add value to Pharma R&D throughout the research pipeline

Lorcan Sherry
Chief Scientific Officer

Keith Bowers
Senior Business Development Manager
More from OracleBio:
Quantitative spatial phenotyping of the tumor microenvironment in NSCLC tissue microarray cores using 6-plex multiplex imaging technology and AI-powered phenotyping analysis
ℹ️ Click the thumbnail image above to view or download the high-resolution poster PDF.This poster, produced in collaboration with Akoya Biosciences, is presented at SITC 2022, Boston, USA. The aim of this study was to utilize Akoya’s multiplexed imaging technology and...
Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach
OracleBio analysis data is presented at at American Society of Clinical Oncology (ASCO) in June 2022. The poster, presented by Marie Cumberbatch from TriStar Technology Group, is collaborative work between TriStar, Ultivue, and OracleBio. The work involved multiplex...
Utilizing Quantitative Digital Pathology techniques for analysis of Hepatitis B liver samples stained with a 12-plex multiplex-IF assay
OracleBio data is presented at the 8th Digital Pathology & AI Congress: USA 2022 in New York. The poster, produced in collaboration with Gilead, involved a comprehensive evaluation of Hepatitis B liver samples stained using a 12-plex assay, with this poster...
Find out more about our Multiplex IF Analysis
OracleBio's Quantitative Digital Pathology Services
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more
